steroid-dependent asthma

• France
• Healthcare
• Pharma & Biotech

Sanofi: Phase 3 study on dupilumab in adults and adolescents with severe, steroid-dependent asthma met its primary endpoint and key secondary endpoints

First study with a biologic to show benefit  in severe steroid-dependent asthma population that enrolled patients regardless of blood eosinophil…